TaVNS Improves the Symptoms of Patients With Moderate to Severe CP/CPPS
RecruitingNCT06287970Phase: NAStarted 2024-03-15
Summary
This trial aims to evaluate the efficacy and safety of transcutaneous auricular vagus nerve stimulation (taVNS) for moderate to severe chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). This
Eligibility
Sex
MALE
Min Age
18 Years
Max Age
50 Years
Locations
Guang'anmen Hospita, China Academy of Chinese Medical SciencBeijing, Beijing Municipality, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06287970